Summary of Significant Accounting Policies (Details Narrative) - USD ($) |
3 Months Ended | 6 Months Ended | ||||
---|---|---|---|---|---|---|
Jun. 30, 2022 |
Jun. 30, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
Dec. 31, 2021 |
Jun. 25, 2021 |
|
Property, Plant and Equipment [Line Items] | ||||||
Percentage of revenue services | 49.00% | 79.00% | ||||
Risks and uncertainties in entitys business | We continue to perform limited testing for uninsured persons and are incurring the accompanying costs. However, as a result of the suspension of the HRSA uninsured program, we did not recognize any revenue related to COVID-19 testing that we performed for uninsured individuals from March 23, 2022 through June 30, 2022 | |||||
Net cash provided by used in operating activities | $ 25,108,000 | $ (3,450,000) | ||||
Cash equivalents at carrying value | $ 27,500,000 | 27,500,000 | ||||
Restricted cash | $ 250,000 | |||||
Fair value of investment securities | $ (164,000) | $ 76,000 | (164,000) | |||
Description of property plant and equipment useful lives | ranges of estimated asset lives: building and improvements - ten to thirty-nine years; machinery and equipment including lab equipment - three to seven years; computer equipment and software - three to five years; and furniture and fixtures - five years | |||||
Cash and cash equivalents and restricted cash balance | 24,000,000.0 | $ 24,000,000.0 | ||||
Federal depository insurance | 900,000 | 900,000 | ||||
Uninsured | 23,100,000 | 23,100,000 | ||||
Breakage revenue | 300,000 | 400,000 | ||||
Contract with customer liability | 3,413,000 | 3,413,000 | 2,939,000 | |||
Deferred revenue | 3,200,000 | 3,200,000 | 2,700,000 | |||
R&D costs incurred | 28,000 | 93,000 | 63,000 | 208,000 | ||
Advertising and Incentive Promotion [Member] | ||||||
Property, Plant and Equipment [Line Items] | ||||||
Advertising and incentive promotion expenses | $ 63,000 | $ 111,000 | $ 124,000 | $ 279,000 | ||
Minimum [Member] | ||||||
Property, Plant and Equipment [Line Items] | ||||||
Contract with customer estimated life | 12 months | |||||
Maximum [Member] | ||||||
Property, Plant and Equipment [Line Items] | ||||||
Contract with customer estimated life | 36 months | |||||
Investment Shares [Member] | ||||||
Property, Plant and Equipment [Line Items] | ||||||
Investment owned balance shares | 1,260,619 | |||||
Investment owned at fairValue | $ 76,000 | $ 315,000 |
X | ||||||||||
- Definition Breakage revenue. No definition available.
|
X | ||||||||||
- Definition Change in fair value of investment securities No definition available.
|
X | ||||||||||
- Definition Contract with customer estimated life. No definition available.
|
X | ||||||||||
- Definition Percentage of Revenue Services. No definition available.
|
X | ||||||||||
- Definition Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation. No definition available.
|
X | ||||||||||
- Definition The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation. No definition available.
|
X | ||||||||||
- Definition Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Balance held at close of period in number of shares. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Description of the risk factors inherent in the entity's business, excluding risks associated with certain significant estimates or concentration risks. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|